Electrical Muscle Stimulation (EMS) for Hip Osteoarthritis Management

Possible Role for Electrical Muscle Stimulation (EMS) for Hip Osteoarthritis Management

Introduction: Hip osteoarthritis (OA) is a prevalent and debilitating condition, particularly in aging populations. Despite over a century of research, effective treatments that can reverse or significantly slow the progression of this disease remain elusive. Surgery, often considered a last resort, may not always yield optimal outcomes, especially in the presence of muscle mass deficiencies or sarcopenia—an age-related decline in muscle strength and quality. This article explores the potential benefits of Electronic Muscle Stimulation (EMS), specifically High-Intensity Electromagnetic Muscle Therapy (HIEMT), as a promising adjunctive treatment for managing hip OA.

Understanding the Role of Sarcopenia in Hip Osteoarthritis: Sarcopenia, characterised by the loss of muscle mass, strength, and function, is a common companion to aging and may exacerbate the severity of hip OA. This condition not only contributes to physical dysfunction but also increases the risk of falls, frailty, and disability. In individuals with hip OA, sarcopenia can accelerate the progression of the disease, leading to further joint deterioration, increased pain, and reduced mobility. Addressing sarcopenia is therefore critical in managing hip OA, particularly in older adults who may already be experiencing muscle wasting due to inactivity or other health issues.

The Potential of Electrical Muscle Stimulation (EMS): EMS, including HIEMT, offers a non-invasive approach to muscle strengthening and rehabilitation. By using electrical impulses to stimulate muscle contractions, EMS can enhance muscle mass and function without the need for voluntary exercise—an important consideration for individuals with severe pain or mobility limitations due to hip OA.

Pain Reduction and Improved Mobility: EMS has been shown to reduce pain and stiffness in joints, which can significantly improve mobility in hip OA patients. By stimulating the muscles surrounding the hip joint, EMS can help maintain muscle mass and strength, thus supporting joint stability and reducing the strain on the hip during movement.
Mitigating Sarcopenia: The ability of EMS to counteract sarcopenia is particularly valuable in hip OA management. By targeting the affected muscles, EMS can help slow or even reverse muscle atrophy, thereby improving overall muscle function. This is crucial for maintaining the joint’s support structure, which can prevent further OA progression and reduce the need for invasive treatments like surgery.
Enhanced Recovery Post-Surgery: For patients undergoing hip replacement surgery, EMS can play a vital role in the post-operative recovery process. Strengthening the muscles before and after surgery can improve surgical outcomes, reduce recovery time, and minimise the risk of complications such as infection or muscle wasting. HIEMT, in particular, has been found to effectively target and strengthen specific muscle fibers, which can be beneficial in restoring muscle function and supporting joint health.
Addressing Obesity-Related Challenges: Obesity, which often accompanies hip OA, can lead to increased fat infiltration in muscles, further compromising muscle function and joint stability. EMS can help reduce muscle fat content while enhancing muscle quality, thus providing a dual benefit of improving both muscle and joint health. This is especially important for older adults who may find traditional exercise difficult due to obesity-related limitations.
Supporting Long-Term Joint Health: Regular application of EMS, particularly in combination with other therapeutic modalities, can provide ongoing support for joint health. By maintaining or improving muscle mass and function, EMS can help delay the progression of OA, reduce the likelihood of falls and fractures, and enhance overall quality of life for individuals with hip OA.

Conclusion: While further research is needed to fully establish the efficacy of EMS in hip OA management, the potential benefits are clear. EMS, including HIEMT, offers a promising approach to mitigating the effects of sarcopenia, reducing pain, and improving mobility in individuals with hip OA. By integrating EMS into treatment protocols, healthcare providers can offer a non-invasive, effective solution that addresses both the symptoms and underlying muscular issues associated with hip OA, ultimately improving patient outcomes and quality of life.

Read the original article

Citation: Marks R. Sarcopenia and hip osteoarthritis: possible role for targeted electrical and biophysical muscle stimulation applications. Int Phys Med Rehab J. 2023;8(1):80-86. DOI: 10.15406/ipmrj.2023.08.00338